Skip to main content
FinSpry Logo
FinSpry
GLUE logo
GLUE
(NASDAQ)
Monte Rosa Therapeutics, Inc.
$18.65-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Monte Rosa Therapeutics (GLUE) Stock Price & Financial Analysis

Monte Rosa Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$17.81 - $18.97
52-Week High$25.77
52-Week Low$3.51
Open$17.93
Volume898.58K
Average Volume (3M)791.12K
Market Cap1.46B
Shares Outstanding83.07M
Price to Sales (P/S)11.81
Price to Book (P/B)6.27
EV/EBITDA-29.87
Revenue (TTM)123.67M
Net Income (TTM)-38.63M
Free Cash Flow (TTM)-27.50M
EPS (TTM)$-0.53
Profit Margin-31.23%
Operating Margin-43.83%
Return on Equity (ROE)-16.57%
Debt to Equity0.17
50-Day MA$17.84
200-Day MA$14.09
52-Week Change374.47%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Monte Rosa Therapeutics

What is the current stock price for GLUE?

As of the latest trading session, GLUE stock trades at $18.65. The 52-week range is $3.51–$25.77, with a day range of $17.81–$18.97.

What is the P/E ratio for GLUE?

The P/E ratio (Price-to-Earnings) for GLUE is shown in the Key Statistics section. This valuation metric helps compare Monte Rosa Therapeutics, Inc. to industry peers.

Does GLUE pay dividends?

Monte Rosa Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for GLUE?

Based on 4 analysts, the consensus for GLUE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of GLUE?

Monte Rosa Therapeutics's market capitalization is $1.55B, classifying it as a small-cap company. Monte Rosa Therapeutics operates in the Healthcare sector within the Biotechnology industry.